Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Healthtrust
Julphar
Mallinckrodt
McKesson
Chubb
Deloitte
Argus Health
Queensland Health

Generated: October 17, 2017

DrugPatentWatch Database Preview

TECZEM Drug Profile

« Back to Dashboard

Which patents cover Teczem, and when can generic versions of Teczem launch?

Teczem is a drug marketed by Biovail and is included in one NDA.

The generic ingredient in TECZEM is diltiazem malate; enalapril maleate. There are twenty-six drug master file entries for this compound. Additional details are available on the diltiazem malate; enalapril maleate profile page.

Summary for Tradename: TECZEM

US Patents:0
Applicants:1
NDAs:1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TECZEM at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Biovail
TECZEM
diltiazem malate; enalapril maleate
TABLET, EXTENDED RELEASE;ORAL020507-001Oct 4, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: TECZEM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Biovail
TECZEM
diltiazem malate; enalapril maleate
TABLET, EXTENDED RELEASE;ORAL020507-001Oct 4, 1996► Subscribe► Subscribe
Biovail
TECZEM
diltiazem malate; enalapril maleate
TABLET, EXTENDED RELEASE;ORAL020507-001Oct 4, 1996► Subscribe► Subscribe
Biovail
TECZEM
diltiazem malate; enalapril maleate
TABLET, EXTENDED RELEASE;ORAL020507-001Oct 4, 1996► Subscribe► Subscribe
Biovail
TECZEM
diltiazem malate; enalapril maleate
TABLET, EXTENDED RELEASE;ORAL020507-001Oct 4, 1996► Subscribe► Subscribe
Biovail
TECZEM
diltiazem malate; enalapril maleate
TABLET, EXTENDED RELEASE;ORAL020507-001Oct 4, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
UBS
Novartis
Boehringer Ingelheim
Covington
Julphar
Chinese Patent Office
Moodys
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot